• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发自我给药制剂以提高醋酸亮丙瑞林的生物利用度。

Development of Self-Administered Formulation to Improve the Bioavailability of Leuprorelin Acetate.

作者信息

Okada Akie, Niki Rina, Inoue Yutaka, Tomita Junki, Todo Hiroaki, Itakura Shoko, Sugibayashi Kenji

机构信息

Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, 1-1 Keyakidai, Sakado 350-0295, Saitama, Japan.

Research Analysis Center, Josai University, 1-1 Keyakidai, Sakado 350-0295, Saitama, Japan.

出版信息

Pharmaceutics. 2022 Apr 3;14(4):785. doi: 10.3390/pharmaceutics14040785.

DOI:10.3390/pharmaceutics14040785
PMID:35456619
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9031317/
Abstract

In recent years, the development of self-injectable formulations has attracted much attention, and the development of formulations to control pharmacokinetics, as well as drug release and migration in the skin, has become an active research area. In the present study, the development of a lipid-based depot formulation containing leuprorelin acetate (LA) as an easily metabolizable drug in the skin was prepared with a novel non-lamellar liquid-crystal-forming lipid of mono--(5,9,13-trimethyl-4-tetradecenyl) glycerol ester (MGE). Small-angle X-ray scattering, cryo-transmission electron microscopy, and nuclear magnetic resonance observations showed that the MGE-containing formulations had a face-centered cubic packed micellar structure. In addition, the bioavailability () of LA after subcutaneous injection was significantly improved with the MGE-containing formulation compared with the administration of LA solution. Notably, higher and faster were obtained with the MGE-containing formulation, and the increased with increasing MGE content in the formulation, suggesting that LA migration into the systemic circulation and its stability might be enhanced by MGE. These results may support the development of self-administered formulations of peptide drugs as well as nucleic acids, which are easily metabolized in the skin.

摘要

近年来,可自我注射制剂的开发备受关注,控制药代动力学以及药物在皮肤中的释放和迁移的制剂开发已成为一个活跃的研究领域。在本研究中,以单 -(5,9,13 - 三甲基 - 4 - 十四碳烯基)甘油酯(MGE)这种新型非层状液晶形成脂质制备了含有醋酸亮丙瑞林(LA)的脂质型长效制剂,LA是一种在皮肤中易代谢的药物。小角X射线散射、冷冻透射电子显微镜和核磁共振观察表明,含MGE的制剂具有面心立方堆积胶束结构。此外,与注射LA溶液相比,含MGE的制剂皮下注射后LA的生物利用度()显著提高。值得注意的是,含MGE的制剂获得了更高且更快的(此处原文可能有误,推测是生物利用度相关参数),并且随着制剂中MGE含量的增加而增加,这表明MGE可能增强了LA向体循环的迁移及其稳定性。这些结果可能支持肽类药物以及在皮肤中易代谢的核酸的自我给药制剂的开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9db/9031317/1f679a2a9cc7/pharmaceutics-14-00785-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9db/9031317/9e998a6bad4d/pharmaceutics-14-00785-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9db/9031317/ec2563064f48/pharmaceutics-14-00785-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9db/9031317/a7999f622c1e/pharmaceutics-14-00785-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9db/9031317/b80962f341cc/pharmaceutics-14-00785-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9db/9031317/e6f4e1484dfa/pharmaceutics-14-00785-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9db/9031317/c98a0f232f54/pharmaceutics-14-00785-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9db/9031317/ff006696fd2a/pharmaceutics-14-00785-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9db/9031317/a262aa937816/pharmaceutics-14-00785-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9db/9031317/1f679a2a9cc7/pharmaceutics-14-00785-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9db/9031317/9e998a6bad4d/pharmaceutics-14-00785-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9db/9031317/ec2563064f48/pharmaceutics-14-00785-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9db/9031317/a7999f622c1e/pharmaceutics-14-00785-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9db/9031317/b80962f341cc/pharmaceutics-14-00785-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9db/9031317/e6f4e1484dfa/pharmaceutics-14-00785-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9db/9031317/c98a0f232f54/pharmaceutics-14-00785-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9db/9031317/ff006696fd2a/pharmaceutics-14-00785-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9db/9031317/a262aa937816/pharmaceutics-14-00785-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9db/9031317/1f679a2a9cc7/pharmaceutics-14-00785-g009.jpg

相似文献

1
Development of Self-Administered Formulation to Improve the Bioavailability of Leuprorelin Acetate.开发自我给药制剂以提高醋酸亮丙瑞林的生物利用度。
Pharmaceutics. 2022 Apr 3;14(4):785. doi: 10.3390/pharmaceutics14040785.
2
Controlled release of a model hydrophilic high molecular weight compound from injectable non-lamellar liquid crystal formulations containing different types of phospholipids.控制模型亲水性高分子化合物从含有不同类型磷脂的可注射非层状液晶制剂中的释放。
Int J Pharm. 2020 Mar 15;577:118944. doi: 10.1016/j.ijpharm.2019.118944. Epub 2019 Dec 21.
3
A Lipid-Based Depot Formulation with a Novel Non-lamellar Liquid Crystal Forming Lipid.一种含有新型非层状液晶形成脂质的基于脂质的储库制剂。
Pharm Res. 2021 Mar;38(3):503-513. doi: 10.1007/s11095-021-03014-y. Epub 2021 Feb 26.
4
Development of Spray Formulations Applied to the Oral Mucosa Using Non-lamellar Liquid Crystal-Forming Lipids.使用非层状液晶形成脂质开发应用于口腔黏膜的喷雾制剂。
Chem Pharm Bull (Tokyo). 2020;68(11):1025-1033. doi: 10.1248/cpb.c20-00333.
5
A Novel Chemical Enhancer Approach for Transdermal Drug Delivery with C-Monoglycerol Ester Liquid Crystal-forming Lipid.一种使用C-单甘油酯液晶形成脂质的新型透皮给药化学增强剂方法。
J Oleo Sci. 2017 May 1;66(5):443-454. doi: 10.5650/jos.ess16204. Epub 2017 Apr 4.
6
Enhancement of Skin Permeation of a Hydrophilic Drug from Acryl-Based Pressure-Sensitive Adhesive Tape.亲水性药物透过丙烯酸类压敏胶带的皮肤渗透增强作用。
Pharm Res. 2021 Feb;38(2):289-299. doi: 10.1007/s11095-021-02996-z. Epub 2021 Jan 29.
7
Clinical pharmacokinetics of depot leuprorelin.长效亮丙瑞林的临床药代动力学
Clin Pharmacokinet. 2002;41(7):485-504. doi: 10.2165/00003088-200241070-00003.
8
Preliminary investigation of the nasal delivery of liposomal leuprorelin acetate for contraception in rats.醋酸亮丙瑞林脂质体经鼻腔给药用于大鼠避孕的初步研究。
J Pharm Pharmacol. 2006 Jan;58(1):19-26. doi: 10.1211/jpp.58.1.0003.
9
Cost analysis of leuprorelin acetate in Japanese prostate cancer patients: comparison between 6-month and 3-month depot formulations.醋酸亮丙瑞林在日本前列腺癌患者中的成本分析:6个月和3个月长效制剂的比较。
J Med Econ. 2017 Nov;20(11):1155-1162. doi: 10.1080/13696998.2017.1362410. Epub 2017 Aug 16.
10
Development and Optimization of Orally and Topically Applied Liquid Crystal Drug Formulations.口服和局部应用液晶药物制剂的研发与优化
J Oleo Sci. 2017;66(9):939-950. doi: 10.5650/jos.ess17032.

本文引用的文献

1
A Lipid-Based Depot Formulation with a Novel Non-lamellar Liquid Crystal Forming Lipid.一种含有新型非层状液晶形成脂质的基于脂质的储库制剂。
Pharm Res. 2021 Mar;38(3):503-513. doi: 10.1007/s11095-021-03014-y. Epub 2021 Feb 26.
2
Enhancement of Skin Permeation of a Hydrophilic Drug from Acryl-Based Pressure-Sensitive Adhesive Tape.亲水性药物透过丙烯酸类压敏胶带的皮肤渗透增强作用。
Pharm Res. 2021 Feb;38(2):289-299. doi: 10.1007/s11095-021-02996-z. Epub 2021 Jan 29.
3
Visualization of supramolecular structure of Pluronic F127 micellar hydrogels using cryo-TEM.
使用冷冻透射电子显微镜观察普朗尼克F127胶束水凝胶的超分子结构
MethodsX. 2020 Sep 28;7:101084. doi: 10.1016/j.mex.2020.101084. eCollection 2020.
4
Advances in oligonucleotide drug delivery.寡核苷酸药物递送的进展。
Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11.
5
Enhanced nose-to-brain delivery of tranilast using liquid crystal formulations.使用液晶制剂增强曲尼司特的鼻腔向脑递药。
J Control Release. 2020 Sep 10;325:1-9. doi: 10.1016/j.jconrel.2020.06.028. Epub 2020 Jun 26.
6
Injectable Lipid-Based Depot Formulations: Where Do We Stand?注射用脂质型长效制剂:我们目前的状况如何?
Pharmaceutics. 2020 Jun 19;12(6):567. doi: 10.3390/pharmaceutics12060567.
7
Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches.口服途径递呈肽类药物:制剂和药物化学方法。
Adv Drug Deliv Rev. 2020;157:2-36. doi: 10.1016/j.addr.2020.05.007. Epub 2020 May 29.
8
Systematic Review on Infusion Reactions to and Infusion Rate of Monoclonal Antibodies Used in Cancer Treatment.癌症治疗中单克隆抗体输注反应和输注率的系统评价。
Anticancer Res. 2020 Mar;40(3):1201-1218. doi: 10.21873/anticanres.14062.
9
Accelerating the development of novel technologies and tools for the subcutaneous delivery of biotherapeutics.加速新型技术和工具的开发,用于生物疗法的皮下给药。
J Control Release. 2020 May 10;321:475-482. doi: 10.1016/j.jconrel.2020.02.036. Epub 2020 Feb 24.
10
Pluronic F127 thermosensitive injectable smart hydrogels for controlled drug delivery system development.用于药物控释系统开发的 Pluronic F127 温敏型注射智能水凝胶。
J Colloid Interface Sci. 2020 Apr 1;565:119-130. doi: 10.1016/j.jcis.2019.12.096. Epub 2019 Dec 23.